13 Best Booming Stocks to Buy Right Now
Despite latest data showing elevated inflation and a decline in retail sales, some major investment firms are looking beyond the short-term market turbulence and issuing highly positive outlook for the...
Cullinan Therapeutics Inc. (CGEM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | BioImpact Capital Mpm Capital | 7,648,268 | $57,897,389 | 9.95% | |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,750,683 | $43,532,670 | 1.77% | |
| 3. | Deerfield Management James E. Flynn | 3,860,839 | $29,226,551 | +15% | 0.58% |
| 4. | Lynx1 Capital Management Weston Nichols | 3,215,722 | $24,343,016 | +156% | 8.72% |
| 5. | Citadel Investment Group Ken Griffin | 2,747,145 | $20,795,888 | +3% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.40 | 8,090 | Officer, Director | 8,090 | 2022-06-06 | Filing | |
| $11.00 | 44,746 | Large Shareholder | 364,161 | 2022-06-01 | Filing | |
| $11.00 | 301,009 | Large Shareholder | 2,992,808 | 2022-06-01 | Filing | |
| $11.00 | 405,641 | Large Shareholder | 4,058,854 | 2022-06-01 | Filing | |
| $9.14 | 17,744 | Large Shareholder | 319,415 | 2022-05-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.53 | 4,895 | 174,164 | 2025-02-25 | Filing | ||
| $8.53 | 12,529 | 430,621 | 2025-02-25 | Filing | ||
| $8.53 | 3,756 | 142,004 | 2025-02-25 | Filing | ||
| $8.53 | 3,756 | 136,895 | 2025-02-25 | Filing | ||
| $12.51 | 4,000 | 95,760 | 2025-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,220,862 | $31,951,923 | 0% | |
| 2. | 3,039,731 | $23,010,763 | 0% | |
| 3. | 2,435,972 | $18,440,308 | 5.95% | |
| 4. | 2,219,761 | $16,803,591 | 0% | |
| 5. | 1,752,679 | $13,267,780 | 0% |
News See All
5 Most Undervalued Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 5 most undervalued biotech stocks to buy according to analysts.
12 Cheap Healthcare Stocks to Buy in 2023
The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades.
12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds.
11 Cheap Value Stocks to Buy According to Seth Klarman
In this article, we discuss the 11 cheap value stocks to buy according to Seth Klarman.
Do Hedge Funds Love Cullinan Oncology, Inc. (CGEM)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is Cullinan Oncology, Inc. (CGEM) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Renaissance Technologies, Tiger Global Management, Livermore Partners, DoubleLine Capital, Frequency Electronics, Inc. (FEIM), Pinterest Inc (PINS), and More
Biden outlined the details of a $1.9 trillion rescue package on Thursday. The “American Rescue Plan” is designed to support households and businesses through the coronavirus pandemic.
Billionaire Hedge Funds
